Management must by now have some basic indicators already about the results of the patients coming off the Lavender study, enough in my mind to make this an informed decision. Hopefully enough to lower the risk to us. I take this announcement as a positive and am happy to wait out the outcome of the phase 3 results.
Hope some can take advantage of the shares suddenly on offer.
Management must by now have some basic indicators already about...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.10 |
Change
-0.150(0.74%) |
Mkt cap ! $2.566B | |||
| Open | High | Low | Value | Volume |
| $20.40 | $20.50 | $19.88 | $4.961M | 246.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 277 | $20.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.15 | 2400 | 1 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.12 |
Change
-0.150 ( 0.58 %) |
||||
| Open | High | Low | Volume | ||
| $20.45 | $20.50 | $19.88 | 139634 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| NEU (ASX) Chart |